Drugs / 0.2% brimonidine/0.5% timolol fixed combination ophthalmic solution
0.2% brimonidine/0.5% timolol fixed combination ophthalmic solution
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00652106 | Jun 2003 → Mar 2004 | glaucoma, ocular hypertension | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 0.2% brimonidine/0.5% timolol fixed combination ophthalmic solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00652106 ↗ |
| Route | Other | “fixed combination ophthalmic solution 1 drop instilled in each eye” NCT00652106 ↗ |